The research behind Sunn Biolabs formulations

Evidence-based ingredients. Pharmaceutical-grade manufacturing. Reviewed by urologists.

At Sunn Biolabs, every formulation begins with peer-reviewed evidence. Our approach isn't to assemble whatever ingredients are trending — it's to build formulas around actives that have been studied in the populations we serve, manufacture them to pharmaceutical-grade standards, and refine them with input from practicing urologists. This page summarizes the published research behind our prostate-health formula PROSTUROL, with links to the original studies on PubMed.

About CP/CPPS

What is chronic prostatitis / chronic pelvic pain syndrome, and why is it hard to treat?

A common condition with few good answers

Chronic prostatitis / chronic pelvic pain syndrome (CP/CPPS), classified by the National Institutes of Health as NIH Category III prostatitis, affects approximately 8% of adult men across pooled population studies (range 2.2–9.7% depending on case definition) [1]. Symptoms typically include pelvic or perineal pain, urinary urgency or discomfort, and flares that can persist for months or years.

Why antibiotics often don't solve it

CP/CPPS is the non-bacterial form of prostatitis. Unlike NIH Category II (chronic bacterial prostatitis, which represents fewer than 10% of chronic prostatitis cases), Category III CP/CPPS is not primarily driven by bacterial infection. This is why antibiotic courses so often fail to resolve symptoms. Two landmark NIH-funded randomized trials support this:

• Nickel et al. 2003 found that six weeks of levofloxacin was not associated with significantly greater symptom improvement than placebo in men with CP/CPPS [2].
• Alexander et al. 2004 found that six weeks of ciprofloxacin, tamsulosin, or the combination did not substantially reduce symptom scores compared with placebo in men with longstanding CP/CPPS [3].

The standard measure: NIH-CPSI

The NIH Chronic Prostatitis Symptom Index (NIH-CPSI), developed and validated by the NIH Chronic Prostatitis Collaborative Research Network in 1999, is the standard outcome measure used in CP/CPPS clinical trials. It covers three domains: pain (4 items), urinary function (2 items), and quality-of-life impact (3 items) [4]. When we cite clinical trials on this page, "improvement in NIH-CPSI scores" is the measure referenced.

The multi-modal approach: UPOINT phenotyping

Because CP/CPPS presents differently in different men, urologists increasingly use a six-domain phenotyping system called UPOINT (Urinary, Psychosocial, Organ-specific, Infection, Neurologic/systemic, Tenderness of pelvic muscles) to guide treatment [5]. Under this framework, evidence-based phytotherapy — including quercetin — is commonly used to address the "Organ-specific" domain alongside other targeted interventions.

PROSTUROL is designed to fit within this multi-modal approach, not to replace it.

The research behind PROSTUROL

What's in the formula, and what's the evidence?

Quercetin (from Quercetin Dihydrate) — the anchor ingredient

Quercetin is a plant bioflavonoid. It is the most-studied ingredient in PROSTUROL and the one with the strongest direct CP/CPPS evidence.

The published trial. In 1999, colleagues at UCLA published a double-blind, placebo-controlled randomized trial of oral quercetin (500 mg twice daily for one month) in 30 men with NIH Category III chronic prostatitis. The quercetin group showed significantly greater improvement in NIH-CPSI symptom scores than the placebo group [6]. This trial is the foundation of the modern evidence base for quercetin in CP/CPPS.

Dedicated review. The lead investigator of the original trial — published a dedicated review of quercetin for CP/CPPS in Urologic Clinics of North America in 2011, summarizing the clinical evidence and describing how quercetin fits into UPOINT-directed multimodal care [7].

Cochrane systematic review. The 2019 Cochrane systematic review of pharmacological interventions for CP/CPPS — covering 99 trials and 9,119 men — concluded that phytotherapy (including quercetin) "probably produces a small decrease in prostatitis symptoms without a greater incidence of adverse events compared with placebo," with moderate- to low-certainty evidence [8].

Mechanism of action. Beyond the clinical trials, quercetin has a well-characterized anti-inflammatory mechanism:

• A 2016 review in Nutrients summarized how quercetin modulates inflammatory signaling pathways (NF-κB, MAPK) and pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) [9].
• A 2012 study in PLoS ONE demonstrated that quercetin inhibits the release of inflammatory mediators from human mast cells — relevant because mast cell activation is a recognized mechanism in CP/CPPS pathophysiology [10].

Saw Palmetto (Serenoa repens)

Saw palmetto has a long traditional use history as a plant extract associated with prostate health. It's widely studied in benign prostatic hyperplasia (BPH) — a different condition from CP/CPPS — where the evidence base is mixed; the 2012 Cochrane review concluded saw palmetto monotherapy at standard, double, and triple doses was not associated with greater BPH symptom improvement than placebo [11], and the NIH-funded CAMUS trial reached a similar conclusion for lower urinary tract symptoms [12].

PROSTUROL includes saw palmetto for its traditional use in supporting prostate health and its mechanistic activity on prostatic tissue (5-alpha-reductase modulation, anti-inflammatory effects on prostate cells) [13]. We include it for its long-standing role in prostate-support formulas, not as a CP/CPPS-specific clinically proven agent.

Cranberry Fruit

Cranberry has the strongest evidence base of any ingredient in PROSTUROL for supporting urinary tract health, particularly in reducing recurrent urinary tract infections. The 2023 Cochrane systematic review (50 RCTs, 8,857 participants) concluded that cranberry products were associated with a reduced number of symptomatic, culture-verified UTIs in women with recurrent UTIs, in children, and in people susceptible to UTIs following bladder interventions [14].

The proposed mechanism is well-characterized: A-type proanthocyanidins in cranberry inhibit the adhesion of P-fimbriated E. coli to bladder wall cells, the first step in most urinary infections [15].

In PROSTUROL, cranberry contributes to the formula's general urinary tract structure-function support.

Bromelain — formulation synergy

Bromelain is a proteolytic (protein-digesting) enzyme derived from pineapple stem. It is included in PROSTUROL for two purposes, both well-documented in the peer-reviewed literature:

Anti-inflammatory support. A 2012 review in Biotechnology Research International summarized bromelain's proteolytic, anti-inflammatory, and anti-edematous properties across multiple therapeutic contexts [16]. A 2004 review of bromelain in osteoarthritis reported that oral bromelain was associated with improvements in pain and swelling across early-phase clinical studies [17].

Absorption of co-administered actives. Quercetin has notoriously low oral bioavailability on its own. Combining quercetin with proteolytic enzymes — specifically bromelain and papain — is the formulation rationale described in the 2003 review in World Journal of Urology for his original CP/CPPS supplement work [18]. This quercetin-plus-enzymes structure is the foundation PROSTUROL builds on.

Papain — digestive-enzyme support

Papain is a proteolytic enzyme from papaya. Like bromelain, it's paired with quercetin in PROSTUROL as part of the proteolytic-enzyme approach to supporting the formulation's overall absorption and anti-inflammatory profile. Papain has traditional use as a digestive enzyme, and clinical work with papaya-derived preparations has shown associations with improvements in gastrointestinal tolerance [19].

We include papain for its role in the quercetin + proteolytic-enzymes formulation family and for its contribution to gastrointestinal tolerance — relevant because many men with pelvic discomfort report sensitivity to supplements that irritate their systems.

Zinc (from Zinc Gluconate)

The prostate is one of the most zinc-concentrated tissues in the human body — healthy prostate tissue accumulates zinc at levels many times higher than most other soft tissues [20]. This is not incidental: zinc plays a role in the prostate's native antimicrobial defense.

The prostatic antibacterial factor. In 1976, Fair and colleagues identified zinc as the active component of the "prostatic antibacterial factor" in expressed prostatic secretion — and documented markedly reduced zinc concentrations in the prostatic fluid of men with chronic bacterial prostatitis compared with controls [21]. This established zinc's role in the prostate's innate antimicrobial defense.

Seminal zinc in prostatitis. Marmar et al. 1975 observed significantly lower seminal zinc levels in men with prostatitis compared with healthy volunteers [22].

PROSTUROL provides 5 mg of zinc (45% Daily Value) per serving as zinc gluconate, a highly bioavailable form. Zinc supports normal immune function and contributes to the mineral environment the prostate naturally maintains.

What makes PROSTUROL different

How PROSTUROL differs from generic "prostate support" supplements

Digestive enzymes for absorption

Quercetin — PROSTUROL's anchor ingredient — has famously low oral bioavailability when taken on its own. A quercetin capsule without absorption support can leave much of the active unused.

PROSTUROL's formulation addresses this directly by including two proteolytic enzymes — bromelain and papain — alongside quercetin. This pairing is not a trend or a marketing choice. It follows the formulation rationale that leading urologists who led the original 1999 quercetin CP/CPPS trial, described in their 2003 review: proteolytic enzymes support the absorption of co-administered actives like quercetin [18].

Designed for sensitive systems

Many men with pelvic discomfort also report sensitivity to standard supplements — stomach upset, heartburn, irritation from capsules with harsh excipients or acidic bases. PROSTUROL's use of papain and bromelain contributes to the formula's gastrointestinal profile: proteolytic enzymes have a long history of use in supporting digestive tolerance, and the formula's excipients (hypromellose capsule, microcrystalline cellulose, magnesium stearate, silicon dioxide) are selected to keep the finished capsule non-acidic and easy on sensitive systems.

Men who have cycled through other prostate-support supplements and found them hard on their stomach often find PROSTUROL easier to tolerate.

Pharmaceutical-grade manufacturing

PROSTUROL is manufactured in a GMP-certified facility to pharmaceutical-grade quality standards. Each batch is assayed for ingredient identity, potency, and contaminants before it leaves the facility. This is not the standard across the dietary supplement industry — it's the standard Sunn Biolabs sets because our customers include men who've been chasing symptom relief for years and deserve formulas made to the same rigor as prescription manufacturing.

Refined by a Medical Advisory Board

PROSTUROL's formulation is reviewed and refined by Sunn Biolabs' Medical Advisory Board, a group of practicing urologists with expertise in chronic prostatitis, pelvic pain, and men's urologic health. Our MAB reviews ingredient selection, dosing, manufacturing protocols, and clinical evidence on an ongoing basis.

Part of a multi-modal approach

PROSTUROL is designed to contribute to the "Organ-specific" domain of a UPOINT-guided multimodal approach to CP/CPPS care — not to replace professional diagnosis or comprehensive treatment. Men experiencing persistent pelvic pain, urinary symptoms, or other symptoms consistent with CP/CPPS should work with a qualified urologist to build a phenotype-directed care plan. Leading urologists have demonstrated that UPOINT-directed multimodal therapy is associated with meaningful symptom improvement in the majority of treated men [23].

Full references

All citations are peer-reviewed and PubMed-indexed. Click a PubMed ID (PMID) to read the original paper.